ProteanFect is the world's first coacervate-based nucleic acid delivery system, utilizing mammalian endogenous proteins to provide an innovative, efficient, and safe solution for gene delivery. By harnessing natural biological mechanisms, ProteanFect facilitates highly effective gene delivery while ensuring optimal compatibility and safety in primary cells and hard-to-transfect cell lines.
PRODUCTS
ProteanFect self-assembles with nucleic acids to form compact, uniform nanoparticles. This enables the encapsulation of hundreds of thousands of nucleic acid molecules within the nanoparticles. These nanoparticles efficiently enter cells, facilitating the release of nucleic acids and enabling high gene expression, while ProteanFect naturally degrades within the cells after delivery.
ProteanFect enables the successful delivery of mRNA into a wide range of primary cells, including T cells, NK cells, stem cells, neurons, cardiomyocytes, and more.
ProteanFect-formed complex encapsulates hundreds of thousands of nucleic acid molecules significantly exceeding the payload capacity of viral approaches.
ProteanFect achieves higher transfection efficiency while the cell viability is naturally enhanced due to its degradation, ensuring both safe and optimal performance.
ProteanFect facilitates the successful transfection of multiple wells with various mRNA sizes, making it ideal for high-throughput applications in large-scale service stores.
富文本部分